# D-serine Augmentation of Neuroplasticity

> **NCT03711500** · PHASE1,PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 45 (actual)

## Conditions studied

- Schizophrenia
- Schizo Affective Disorder

## Interventions

- **DRUG:** D-serine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03711500
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-13
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2022-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03711500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03711500, "D-serine Augmentation of Neuroplasticity". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03711500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*